Dr. Delia Cabrera DeBuc, a biophysicist and Research Associate Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, earned her Ph.D. in Applied Physics from the University of Michigan in 2002. Specializing in ocular imaging technology and image analysis, she leads a research group supported by various grants, including those from the Juvenile Diabetes Research Foundation, the National Institute of Health, the Alzheimer's Association, the National Institute on Aging, the Finker Frenkel Legacy Foundation and the National Eye Institute. Her focus is on the medical applications of ultrafast laser technology and optical imaging, particularly in the context of the human eye.
Dr. DeBuc explores novel ocular biomarkers in neurodegenerative diseases such as diabetic retinopathy and Alzheimer's. She integrates Artificial Intelligence (AI) into disease diagnosis, emphasizing a multimodal approach. Her lab collaborates nationally and internationally, utilizing AI/ML and brain–computer interfaces to understand the connections between the eye and brain, aiming to advance early disease detection. She is the Guest Editor of the Special Issue "Development and Application of Imaging Analysis in Ocular Diseases" at MDPI and the "Ocular Biomarkers" Collection in Scientific Reports. Her scientific output includes 204 publications, corresponding to 3998 citations (h-index 33, i10-index 60) (Google Scholar, 21 November 2023).
Dr. Delia Cabrera DeBuc, a biophysicist and Research Associate Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, earned her Ph.D. in Applied Physics from the University of Michigan in 2002. Specializing in ocular imaging technology and image analysis, she leads a research group supported by various grants, including those from the Juvenile Diabetes Research Foundation, the National Institute of Health, the Alzheimer's Association, the National Institute on Aging, the Finker Frenkel Legacy Foundation and the National Eye Institute. Her focus is on the medical applications of ultrafast laser technology and optical imaging, particularly in the context of the human eye.
Dr. DeBuc explores novel ocular biomarkers in neurodegenerative diseases such as diabetic retinopathy and Alzheimer's. She integrates Artificial Intelligence (AI) into disease diagnosis, emphasizing a multimodal approach. Her lab collaborates nationally and internationally, utilizing AI/ML and brain–computer interfaces to understand the connections between the eye and brain, aiming to advance early disease detection. She is the Guest Editor of the Special Issue "Development and Application of Imaging Analysis in Ocular Diseases" at MDPI and the "Ocular Biomarkers" Collection in Scientific Reports. Her scientific output includes 204 publications, corresponding to 3998 citations (h-index 33, i10-index 60) (Google Scholar, 21 November 2023).